What's Going On With MoonLake Stock Monday? - MoonLake (NASDAQ:MLTX)

MoonLake Immunotherapeutics (MLTX) announces positive Phase 3 psoriatic arthritis trial results. Cash runway backed through mid-2028.

Raccontata dabenzinga.com